These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33346523)
1. Evaluation of Clinical Properties and Treatment Responses of Infantile Hemangioma. Yildirimcakar D; Demirsoy U; Azizoglu M; Corapcioglu F J Drugs Dermatol; 2020 Dec; 19(12):1156-1165. PubMed ID: 33346523 [TBL] [Abstract][Full Text] [Related]
2. [What's new about infantile hemangiomas?]. Dreyfus I; Maza A; Mazereeuw-Hautier J Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116 [TBL] [Abstract][Full Text] [Related]
3. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551 [TBL] [Abstract][Full Text] [Related]
4. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329 [TBL] [Abstract][Full Text] [Related]
5. Current trends in medical management of infantile hemangioma. Ames JA; Sykes JM Curr Opin Otolaryngol Head Neck Surg; 2015 Aug; 23(4):286-91. PubMed ID: 26101875 [TBL] [Abstract][Full Text] [Related]
6. Subglottic hemangioma: Understanding the association with facial segmental hemangioma in a beard distribution. McCormick AA; Tarchichi T; Azbell C; Grunwaldt L; Jabbour N Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():34-37. PubMed ID: 30174006 [TBL] [Abstract][Full Text] [Related]
7. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy]. Michel JL; Patural H Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536 [TBL] [Abstract][Full Text] [Related]
12. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration. Lie E; Püttgen KB Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792 [TBL] [Abstract][Full Text] [Related]
13. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review]. Yilmaz L; Dangoisse C; Semaille P Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868 [TBL] [Abstract][Full Text] [Related]
14. Infantile hemangiomas, complications and treatments. Cheng CE; Friedlander SF Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318 [TBL] [Abstract][Full Text] [Related]
15. Propranolol for recalcitrant ulcerated hemangioma of infancy. Hong E; Fischer G Pediatr Dermatol; 2012; 29(1):64-7. PubMed ID: 21854419 [TBL] [Abstract][Full Text] [Related]
16. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120 [TBL] [Abstract][Full Text] [Related]
17. Treatment of infantile hemangiomas with propranolol: clinical guidelines. Szychta P; Stewart K; Anderson W Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207 [TBL] [Abstract][Full Text] [Related]
18. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031 [TBL] [Abstract][Full Text] [Related]
19. [Management of ulcers on a segmental hemangioma: A combination of systemic and topical therapies in two pediatric cases]. Tirelli LL; Luna PC; Panizzardi AA; Larralde M Arch Argent Pediatr; 2022 Oct; 120(5):e226-e230. PubMed ID: 36190226 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for infantile hemangioma--a case control study. Rasul S Eur J Pediatr Surg; 2014 Feb; 24(1):102-12. PubMed ID: 24008548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]